February 2022 FDA Recall Drug by Baycare Integrated Service Center, Llc /dba Baycare Central Pharmacy
D-0569-2022 - Subpotent drug
This Class III drug recall was voluntarily initiated by Baycare Integrated Service Center, Llc /dba Baycare Central Pharmacy on February 14, 2022 for the product Drug. The FDA reported the reason for recall as subpotent drug. The product was distributed in Florida and the recall is currently terminated.
Recall Number: D-0569-2022
Subpotent drug
02-14-2022
03-02-2022
1157 bags
Recall Profile & Regulatory Data
Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
BayCare Integrated Service Center, LLC /dba BayCare Central Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
Florida
12-08-2022
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
Norepinephrine bitartrate 16 mg in 250 mL NaCl 0.9%, packaged in IV bags, Rx only, BayCare Central Pharmacy 7802 E. Telecom Parkway Temple Terrace, FL 33637 (813) 901-6392
Batch or Lot Expiration Information
Lot# : Nore1620220111, Nore1620220113, Nore1620220118, Nore1620220125, Nore1620220127, Nore1620220202, Exp 3/31/22